MicroRNA-152 targets ADAM17 to suppress NSCLC progression

被引:64
|
作者
Su, Yunshu [1 ]
Wang, Yuchang [1 ]
Zhou, Hongmin [1 ]
Lei, Lei [1 ]
Xu, Lijun [1 ]
机构
[1] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Cardiothorac Surg, Wuhan 430030, Hubei, Peoples R China
来源
FEBS LETTERS | 2014年 / 588卷 / 10期
关键词
Non-small cell lung cancer; miR-152; ADAM metallopeptidase domain 17; Proliferation; Migration; Invasion; MESSENGER-RNA EXPRESSION; CELL LUNG-CANCER; HEPATOCELLULAR-CARCINOMA; GROWTH; PROMOTES; MOTILITY; INVASION; MIR-152; FAMILY;
D O I
10.1016/j.febslet.2014.04.022
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
MicroRNAs (miRNAs) are a class of small non-coding RNAs that have been suggested to play an essential role in tumorigenesis. In this study, we show that miR-152 is significantly downregulated in non-small cell lung cancer (NSCLC) tissues and cell lines. Restoration of miR-152 significantly reduces proliferation, colony formation, migration and invasion of NSCLC cells. In addition, ADAM metallopeptidase domain 17 (ADAM17) is identified as a target of miR-152 in NSCLC cells, and miR-152-induced suppression of cell proliferation, colony formation, migration and invasion is partially mediated by silencing of ADAM17 expression. Furthermore, ADAM17 inversely correlates with miR-152 in NSCLC tissues. Collectively, our findings indicate that miR-152 acts as tumor suppressor in NSCLC partially via targeting ADAM17. (C) 2014 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.
引用
收藏
页码:1983 / 1988
页数:6
相关论文
共 49 条
  • [1] ADAM17, shedding, TACE as therapeutic targets
    Rose-John, Stefan
    PHARMACOLOGICAL RESEARCH, 2013, 71 : 19 - 22
  • [2] MicroRNA-145 Targets the Metalloprotease ADAM17 and Is Suppressed in Renal Cell Carcinoma Patients
    Doberstein, Kai
    Steinmeyer, Nico
    Hartmetz, Ann-Kathrin
    Eberhardt, Wolfgang
    Mittelbronn, Michel
    Harter, Patrick N.
    Juengel, Eva
    Blaheta, Roman
    Pfeilschifter, Josef
    Gutwein, Paul
    NEOPLASIA, 2013, 15 (02): : 218 - U153
  • [3] The role of ADAM17 in tumorigenesis and progression of breast cancer
    Shen, Hongyu
    Li, Liangpeng
    Zhou, Siying
    Yu, Dandan
    Yang, Sujin
    Chen, Xiu
    Wang, Dandan
    Zhong, Shanliang
    Zhao, Jianhua
    Tang, Jinhai
    TUMOR BIOLOGY, 2016, 37 (12) : 15359 - 15370
  • [4] LncRNA HAGLROS accelerates the progression of lung carcinoma via sponging microRNA-152
    Wang, W-L
    Yu, D. J.
    Zhong, M.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2019, 23 (15) : 6531 - 6538
  • [5] The "A Disintegrin And Metalloproteases" ADAM10 and ADAM17: Novel drug targets with therapeutic potential?
    Saftig, Paul
    Reiss, Karina
    EUROPEAN JOURNAL OF CELL BIOLOGY, 2011, 90 (6-7) : 527 - 535
  • [6] The A Disintegrin And Metalloproteases ADAM10 and ADAM17 as potential novel targets in multiple myeloma
    Burger, R.
    Klenner, B.
    Klausz, K.
    Staudinger, M.
    Garbers, C.
    Guenther, A.
    Gramatzki, M.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 84 - 84
  • [7] ADAM17 and TRKA receptor are involved in epithelial ovarian cancer progression
    Girardi, Silvana
    Tapia, Veronica
    Kohan, Karla
    Contreras, Hector
    Gabler, Fernando
    Selman, Alberto
    Vega, Margarita
    Romero, Carmen
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2012, 30 : S13 - S13
  • [8] MicroRNA-152 specifically targets kinesin family member 14 to suppress the advancement of bladder cancer cells via PI3K/AKT pathway
    Meng, Fang
    Zhang, Zhensheng
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2024, 692
  • [9] Association Study Between Promoter Polymorphisms of ADAM17 and Progression of Sepsis
    Shao, Yiming
    He, Junbing
    Chen, Feng
    Cai, Yujie
    Zhao, Jianghao
    Lin, Yao
    Yin, Zihan
    Tao, Hua
    Shao, Xin
    Huang, Pengru
    Yin, Mingkang
    Zhang, Wenying
    Liu, Zhou
    Cui, Lili
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2016, 39 (04) : 1247 - 1261
  • [10] MicroRNA-152 targets DNA methyltransferase 1 in NiS-transformed cells via a feedback mechanism
    Ji, Weidong
    Yang, Lei
    Yuan, Jianhui
    Yang, Linqing
    Zhang, Mei
    Qi, Defeng
    Duan, Xiaolu
    Xuan, Aiguo
    Zhang, Wenjuan
    Lu, Jiachun
    Zhuang, Zhixiong
    Zeng, Guohua
    CARCINOGENESIS, 2013, 34 (02) : 446 - 453